Lisata Therapeutics, Inc. (LSTA) — Dilution Risk Analysis
Current Snapshot
Lisata Therapeutics, Inc. (LSTA) has a DilutionWatch score of 52/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 52/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 9, XBRL 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-01-13 | 0001309653-26-000004 |
| 4 | 2026-01-13 | 0001373585-26-000003 |
| 4 | 2026-01-13 | 0001741455-26-000003 |
| 4 | 2026-01-13 | 0001283301-26-000003 |
| 4 | 2026-01-13 | 0001192621-26-000004 |
| 4 | 2026-01-13 | 0001879231-26-000003 |
| 4 | 2026-01-13 | 0002055011-26-000003 |
| 4 | 2026-01-13 | 0002020260-26-000003 |
| 4 | 2026-01-13 | 0001334549-26-000003 |
| xbrl | 2010-12-31 | xbrl-6161-xbrl_convertible |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 5 months | Source |
| Three-year share count growth | 10.71% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 52/10) Source
- Cash Runway
- 5 months Source
- Share Count Growth (3-Year)
- 10.71% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.